Evidence map›Paper›PMID 36806390›Full record

ArticleMolecular psychiatry2023

GWAS-identified bipolar disorder risk allele in the FADS1/2 gene region links mood episodes and unsaturated fatty acid metabolism in mutant mice.

Hirona Yamamoto, Hyeon-Cheol Lee-Okada, Masashi Ikeda, Takumi Nakamura, Takeo Saito, Atsushi Takata, Takehiko Yokomizo, Nakao Iwata, Tadafumi Kato, Takaoki Kasahara

Open access · hybridAbstract read
In one paragraph

Article in Molecular psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
16.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Hirona YamamotoLaboratory for Molecular Dynamics of Mental Disorders, RIKEN Center for Brain Science, Saitama, Japan.
Hyeon-Cheol Lee-OkadaDepartment of Biochemistry, Juntendo University School of Medicine, Tokyo, Japan.ORCID 0000-0002-5493-8112
Masashi IkedaDepartment of Psychiatry, Fujita Health University School of Medicine, Aichi, Japan.ORCID 0000-0001-6237-2449
Takumi NakamuraLaboratory for Molecular Pathology of Psychiatric Disorders, RIKEN Center for Brain Science, Saitama, Japan.ORCID 0000-0002-5611-6534
Takeo SaitoDepartment of Psychiatry, Fujita Health University School of Medicine, Aichi, Japan.
Atsushi TakataLaboratory for Molecular Pathology of Psychiatric Disorders, RIKEN Center for Brain Science, Saitama, Japan.ORCID 0000-0002-0928-4586
Takehiko YokomizoDepartment of Biochemistry, Juntendo University School of Medicine, Tokyo, Japan.
Nakao IwataDepartment of Psychiatry, Fujita Health University School of Medicine, Aichi, Japan.ORCID 0000-0003-3189-6076
Tadafumi KatoLaboratory for Molecular Dynamics of Mental Disorders, RIKEN Center for Brain Science, Saitama, Japan. tadafumi.kato@juntendo.ac.jp.ORCID 0000-0001-7856-3952
Takaoki KasaharaLaboratory for Molecular Dynamics of Mental Disorders, RIKEN Center for Brain Science, Saitama, Japan. takaoki.kasahara@uni-oldenburg.de.ORCID 0000-0002-0953-5146
RIKEN Center for Brain Science · JPFujita Health University · JPJuntendo University · JPCarl von Ossietzky Universität Oldenburg · DE

Funding

Japan Agency for Medical Research and Development (AMED) JP16dm0107098Japan Agency for Medical Research and Development (AMED) JP20dm017097Japan Agency for Medical Research and Development (AMED) JP22wm0425008
6 · The paper itself

Abstract

Large-scale genome-wide association studies (GWASs) on bipolar disorder (BD) have implicated the involvement of the fatty acid desaturase (FADS) locus. These enzymes (FADS1 and FADS2) are involved in the metabolism of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are thought to potentially benefit patients with mood disorders. To model reductions in the activity of FADS1/2 affected by the susceptibility alleles, we generated mutant mice heterozygously lacking both Fads1/2 genes. We measured wheel-running activity over six months and observed bipolar swings in activity, including hyperactivity and hypoactivity. The hyperactivity episodes, in which activity was far above the norm, usually lasted half a day; mice manifested significantly shorter immobility times on the behavioral despair test performed during these episodes. The hypoactivity episodes, which lasted for several weeks, were accompanied by abnormal circadian rhythms and a marked decrease in wheel running, a spontaneous behavior associated with motivation and reward systems. We comprehensively examined lipid composition in the brain and found that levels of certain lipids were significantly altered between wild-type and the heterozygous mutant mice, but no changes were consistent with both sexes and either DHA or EPA was not altered. However, supplementation with DHA or a mixture of DHA and EPA prevented these episodic behavioral changes. Here we propose that heterozygous Fads1/2 knockout mice are a model of BD with robust constitutive, face, and predictive validity, as administration of the mood stabilizer lithium was also effective. This GWAS-based model helps to clarify how lipids and their metabolisms are involved in the pathogenesis and treatment of BD.

Indexed as

Bipolar DisorderGenome-Wide Association StudyAllelesAnimalsDocosahexaenoic AcidsEicosapentaenoic AcidFemaleHumansMaleMiceMotor ActivityPolymorphism, Single NucleotideDocosahexaenoic AcidsEicosapentaenoic Acid

Identifiers

PMID36806390
PMCPMC10615742
OpenAlexW4321366315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.